This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Seattle Children's Hospital Dba Seattle Children's Research Institute. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: James F Matthaei: Innovator in Chimeric Antigen Receptors
Introduction
James F Matthaei is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biomedical research, particularly in the development of chimeric antigen receptors. His work is instrumental in advancing therapeutic strategies for various diseases.
Latest Patents
James F Matthaei holds a patent for "Anti-Dinitrophenol Chimeric Antigen Receptors." This innovative patent reflects his commitment to enhancing medical treatments and improving patient outcomes. He has 1 patent to his name, showcasing his contributions to the scientific community.
Career Highlights
Matthaei is affiliated with Seattle Children's Hospital, doing business as Seattle Children's Research Institute. His role at this esteemed institution allows him to collaborate with other leading researchers and contribute to groundbreaking studies in pediatric medicine.
Collaborations
Throughout his career, Matthaei has worked alongside esteemed colleagues, including Michael C Jensen and Joseph K Cheng. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
James F Matthaei's work in the development of chimeric antigen receptors exemplifies the impact of innovative research in medicine. His contributions continue to inspire future advancements in healthcare.